| Ticker Details |
Medtronic plc
Medtronic PLC is a medical technology company. It is primarily manufactures and sells device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$105.46B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.68 | 1.00%
|
| Avg Daily Range (30 D): |
$1.28 | 1.62%
|
| Avg Daily Range (90 D): |
$1.07 | 1.29%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.2M |
| Avg Daily Volume (30 D): |
8.36M |
| Avg Daily Volume (90 D): |
7.53M |
| Trade Size |
| Avg Trade Size (Sh.): |
138 |
| Avg Trade Size (Sh.) (30 D): |
77 |
| Avg Trade Size (Sh.) (90 D): |
75 |
| Institutional Trades |
| Total Institutional Trades: |
113,471 |
| Avg Institutional Trade: |
$4.93M |
| Avg Institutional Trade (30 D): |
$11.78M |
| Avg Institutional Trade (90 D): |
$9.94M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
19 |
| Market Closing Trades |
| Avg Closing Trade: |
$49.08M |
| Avg Closing Trade (30 D): |
$163.31M |
| Avg Closing Trade (90 D): |
$130.18M |
| Avg Closing Volume: |
594.27K |
|
|
| Financials |
| |
TTM |
Q4 2026 |
FY 2026 |
|
Basic EPS
|
$3.75
|
|
$3.75
|
|
Diluted EPS
|
$3.73
|
|
$3.73
|
|
Revenue
|
$36.36B
|
|
$36.36B
|
|
Gross Profit
|
$23.64B
|
|
$23.64B
|
|
Net Income / Loss
|
$4.84B
|
|
$4.84B
|
|
Operating Income / Loss
|
$6.47B
|
|
$6.47B
|
|
Cost of Revenue
|
$12.72B
|
|
$12.72B
|
|
Net Cash Flow
|
$-270M
|
|
$-270M
|
|
PE Ratio
|
|
|
|
|
|
|
